The firm reported a 27.5 percent decline in net profit at Rs 554 crore as against Rs 764 crore in the year-ago quarter.
Pharma major Dr Reddy's Laboratories March quarter profit missed analysts' estimates. The firm reported a 27.5 percent decline in net profit at Rs 554 crore as against Rs 764 crore in the year-ago quarter.
CNBC-TV18 had estimated a profit of Rs 654.80 crore in the March quarter for the pharma major.
Revenue, meanwhile, rose marginally, nearly 7 percent to Rs 4,728 crore in the quarter under review versus Rs 4,432 crore in the year-ago period.
EBITDA also grew by 13 percent YoY to Rs 1,133 crore in Q4 while EBITDA margin was up 140 bps to 24 percent versus 22.6 percent in Q4FY20.
The pharma major has declared a dividend of Rs 25 per share.
(Edited by : Pranati Deva)
First Published: IST